Independent Medical Education Grant Opportunity: Urothelial Cancer and Muscle-Invasive Bladder Cancer (2026)
The Astellas–Pfizer Alliance is offering competitive grants to support independent medical education initiatives focused on locally advanced or metastatic urothelial cancer (la/mUC) and muscle-invasive bladder cancer (MIBC).
This grant program aims to enhance healthcare professionals’ understanding of emerging treatments, regional variations in care, and guideline adoption—ultimately improving patient outcomes in bladder cancer.
Funding Available: Up to $200,000 per Project for Independent Medical Education on Locally Advanced/Metastatic Urothelial Cancer (la/mUC) and Muscle-Invasive Bladder Cancer (MIBC)
Grant Overview
- Purpose: To fund independent medical education activities that address critical knowledge gaps in the management of la/mUC and MIBC.
- Total Budget: $750,000 (distributed across multiple projects).
- Funding per Project: $10,000 – $200,000.
- Application Deadline: January 31, 2026.
Key Focus Areas for Educational Projects
Proposals should target:
- Knowledge gaps in the management of la/mUC and MIBC.
- Emerging treatments, including combinations involving Enfortumab Vedotin (e.g., with immunotherapy).
- Regional variations in treatment practices and adoption of clinical guidelines.
These topics are essential as urothelial carcinoma remains a challenging disease, with evolving therapies like antibody-drug conjugates transforming care for advanced bladder cancer.
Eligibility Criteria
Eligible Organizations:
- Medical or nursing schools
- Healthcare institutions
- Professional organizations/societies
- Accredited medical education companies
Not Eligible:
- Individual physicians
- Private practices or groups of individual healthcare providers
If your program offers continuing education (CE) credits, it must be submitted by an accredited organization.
Priority Geographic Regions:
- Europe
- Canada
- China
- Middle East
- Russia
- Turkey
- Latin America
- Asia-Pacific
- Australia
- Taiwan
Eligible Costs
- Direct project costs (e.g., faculty honoraria, venue, materials)
- Institutional overhead (up to 22%)
- Indirect costs
How to Apply
Submit a detailed proposal including:
- Clear learning objectives
- Target audience (e.g., oncologists, urologists, nurses)
- Educational methods and format
- Expected outcomes and evaluation metrics
- Detailed budget breakdown
Applications must demonstrate independence and alignment with the program’s focus areas.
This is a competitive grant program from the Astellas–Pfizer Alliance, supporting high-quality, independent education to advance bladder cancer care globally. Don’t miss the January 31, 2026 deadline—apply today to make an impact in urothelial cancer education and MIBC management!